Anti-SARS-CoV-2 Spike Glycoprotein RBD Antibody [2G1]

Anti-SARS-CoV-2 Spike Glycoprotein RBD Antibody [2G1] is a primary antibody directed against SARS-CoV-2 Spike Glycoprotein RBD and supplied in a 100 µl pack. Clone [2G1] identifies this reagent among primary antibodies used in immunology and life-science laboratories. Listed physical properties include a density of 1 g/cm³ and a weight of 0,011 kg. The 100 µl unit from manufacturer antibodies.com is a compact primary-antibody presentation for laboratory handling. Anti-SARS-CoV-2 Spike Glycoprotein RBD Antibody [2G1] is placed in the life science, immunology, antibodies and primary antibodies categories. Clone [2G1] distinguishes this RBD-specific primary antibody from other clones against the same target. Pack size is 100 µl, in line with the stated unit quantity, and density (D) is 1 g/cm³. The recorded weight of 0,011 kg reflects this small 100 µl pack. As a primary antibody against SARS-CoV-2 Spike Glycoprotein RBD, the product is intended for immunological laboratory use where a clone-defined RBD reagent is specified. The antibody is therefore offered as a 100 µl primary antibody with clone [2G1], a density of 1 g/cm³ and a weight of 0,011 kg.

Key features

• Pack size: 100 µl
• Density: 1 g/cm³
• Storage temperature: -20 °C
• Antibody type: Primary antibody
• Clone: [2G1]
• Target: SARS-CoV-2 Spike Glycoprotein RBD
• UNSPSC: 41116126
• Technical Information Sheet:
• Safety Data Sheet: